Home The Active Ingredient Matrix Haematococcus pluvialis (Astaxanthin)

Formulation Intelligence

Haematococcus pluvialis (Astaxanthin)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Haematococcus pluvialis (Astaxanthin).

A potent xanthophyll carotenoid that functions as a high-capacity singlet oxygen quencher and membrane-spanning antioxidant, primarily utilized for mitigating systemic oxidative stress and enhancing dermal and ocular photoprotection.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

5281224

Molecular Weight

596.8 g/mol

XLogP3 (Lipophilicity)

10.3

IUPAC Name

(6S)-6-hydroxy-3-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(4S)-4-hydroxy-2,6,6-trimethyl-3-oxocyclohexen-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-2,4,4-trimethylcyclohex-2-en-1-one

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

  • Lutein for synergistic macular pigment density enhancement
  • Tocopherols for preventing oxidative degradation of the polyene chain

Biological Formulation Enhancers

  • Medium-Chain Triglycerides for enhanced lipid-phase micellar solubilization
  • Phosphatidylcholine for improved intestinal lymphatic transport

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Haematococcus pluvialis (Astaxanthin) across standard consumer modalities.

💊 Standard Capsules

The high sensitivity of the polyene chain to photo-oxidation and thermal degradation necessitates the use of opaque shells and nitrogen-blanketed encapsulation processes.

🍬 Gummy & Pectin Formats

The intense pigment density of the oleoresin causes significant cross-contamination risks and requires precise emulsification to prevent oil-bleeding from the pectin matrix.

🔬 Thin-Film Oral Strips

The hydrophobic nature and required therapeutic dosage of the oleoresin exceed the typical loading capacity and structural integrity limits of hydrophilic polymer thin-film matrices.

For Brand Founders

Formulate with Haematococcus pluvialis (Astaxanthin)

Ready to launch a product featuring Haematococcus pluvialis (Astaxanthin)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Haematococcus pluvialis (Astaxanthin) Bioavailability

Need absolute proof that your Haematococcus pluvialis (Astaxanthin) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Haematococcus pluvialis (Astaxanthin) Degradation Testing

Is your Haematococcus pluvialis (Astaxanthin) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation